| Takeda Pharma AG - Livtencity 200 mg, Filmtabletten |
| 68492 | | 01 | | Livtencity 200 mg | | Filmtabletten | | J05AX10 | | Maribavir | | 19.07.2023 | | |
|
| Composition |
| maribavirum 200 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350 E 171 talcum E 133 pro compresso obducto corresp. natrium max. 0.105 mg. |
| Packungsbestandteile |
| Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Maribavirum | 200 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Maribavirum | 200 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) Macrogolum | 3350 | Überzug | | Pro Compresso Obducto | | | | Talcum E | 133 | |
| |
|
|
